Increased frequency of FBN1 frameshift and nonsense mutations in Marfan syndrome patients with aortic dissection
Open Access
- 12 December 2019
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 8 (1) , e1041
Abstract
Background: Marfan syndrome (MFS) is an inherited connective tissue disease that mainly involves Fibrillin‐1 (FBN1) mutations and aortic manifestations. In this study, we investigated the correlations between the FBN1 genotype–phenotype and aortic events (aortic dissection and aortic aneurysm) in patients with Marfan syndrome.Methods: Genotype and phenotype information was evaluated in 180 patients with MFS. DNA sequencing was performed on each patient. According to the clinical manifestation, these patients were split into two groups: the aortic dissection group and the aortic aneurysm group. Aortic wall tissue was obtained from Marfan patients who underwent surgery and was used for staining.Results: A total of 180 patients with FBN1 mutations were grouped into four categories: 90 with missense mutations, 32 with splicing mutations, 29 with frameshift mutations, and 29 with nonsense mutations. There was a significantly higher frequency of frameshift and nonsense mutations observed in aortic dissection than in aortic aneurysm (25.58% vs. 4.35%, p = .005; 25.58% vs. 8.70%, p = .033, respectively;), while missense mutations showed a higher frequency in aortic aneurysm than in aortic dissection (69.57% vs. 32.56%, respectively; p < .001) and a higher rate of lens dislocation (34.78% vs. 13.95%, respectively; p = .008). Pathological staining showed that elastic fibers were sparser in patients with a frameshift and nonsense mutations, and the smooth muscle cells were sparser and more disorganized than those observed in patients with missense mutations.Conclusion: This study showed that FBN1 gene frameshift and nonsense mutations are more common in patients with aortic dissection and may have meaningful guidance for the treatment of Marfan syndrome patients.Keywords
Funding Information
- National Key R&D Program of China (2017YFC1308000)
- the Beijing Lab for Cardiovascular Precision Medicine (PXM2017_014226_000037)
This publication has 19 references indexed in Scilit:
- Survival, causes of death, and cardiovascular events in patients with Marfan syndromeMolecular Genetics & Genomic Medicine, 2018
- Heritable Thoracic Aortic Disease Genes in Sporadic Aortic DissectionJACC, 2017
- Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan SyndromeCirculation: Cardiovascular Genetics, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic eventsGenetics in Medicine, 2015
- The revised Ghent nosology for the Marfan syndrome: Table 1Journal of Medical Genetics, 2010
- Simple Risk Models to Predict Surgical Mortality in Acute Type A Aortic Dissection: The International Registry of Acute Aortic Dissection ScoreThe Annals of Thoracic Surgery, 2007
- Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndromeHuman Mutation, 2005
- A comparison of the Berlin and Ghent nosologies and the influence of dural ectasia in the diagnosis of Marfan syndromeGenetics in Medicine, 2000
- Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin geneNature, 1991